Dolutegravir plus lamivudine dual therapy – a new option for initial antiretroviral therapy.
Madiha Fida, Stacey A. Rizza, Zelalem Temesgen
págs. 297-304
Lenvatinib mesylate to treat hepatocellular carcinoma.
Luca Ielasi, Francesco Tovoli, Fabio Piscaglia
págs. 305-313
Patisiran for the treatment of patients with familial amyloid polyneuropathy.
Malak Rizk, Şükrü Tüzmen
págs. 315-327
LDL cholesterol-lowering therapies: emphasis on proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors.
Fernando Sabatel Pérez, Álvaro García Ropero, Carlos G. Santos Gallego, Mohammad Urooj Zafar, Juan José Badimón
págs. 329-344
BIO-Europe Spring 2019 - 13th Annual international partnering conference (March 25-27, 2019 - Vienna, Austria)
A Al-Shamahi
págs. 345-349
New product intros [17beta-estradiol/progesterone (new combination), mirogabalin besylate, netarsudil mesylate/latanoprost (new combination), RTS,S/AS01, siponimod fumarate, tafenoquine succinate (new indication)].
págs. 351-353
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: